We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Simple Testing Strategy Aims To Improve Time-Release Drugs

News   Nov 25, 2020 | Original story from UC Riverside

 
Simple Testing Strategy Aims To Improve Time-Release Drugs

A piece of glass bent like a tuning fork measures dissolution of time-release drugs. Credit: William Grover

 
 
Advertisement
 

RELATED ARTICLES

Cross Reactivity Seen Between SARS-CoV-2 and Antibodies to 2003 SARS Outbreak Virus

News

A new study demonstrates that antibodies generated by the novel coronavirus react to other strains of coronavirus and vice versa.

READ MORE

FDA Approves Vericiguat for Use in Patients With Heart Failure

News

The US Food and Drug Administration (FDA) has approved the cardiovascular drug vericiguat. The drug is a once-daily oral treatment for patients with worsening chronic heart failure.

READ MORE

Preventing Chemotherapy From Damaging the Heart

News

Researchers have discovered that the chemotherapy drug doxorubicin is able to enter heart cells by hitchhiking on a specific type of protein that functions as a transporter to move drugs from the blood into heart cells. By introducing another anti-cancer drug in advance of the chemotherapy, the team was able to block the transporter protein.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE